Bioclinica moves to New Princeton, New Jersey Office

Friday, October 6, 2017

Bioclinica, a provider of scientific-enabled Medical Imaging and eHealth solutions in clinical trials, hosted New Jersey Lt. Governor Kim Guadagno, clients and partners in an open house to celebrate the official opening of its new and larger Princeton, New Jersey facility. Following an official ribbon-cutting, guests toured the space, getting an insider’s view into the company’s work, which has supported the global regulatory approvals of more than 150 new medical treatments in Oncology, Neurosciences, Musculoskeletal and other therapeutic areas.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

Preparing sites for acquisition

Saturday, July 1, 2017

The unprecedented level of M&A activity in the clinical research site sector during the past 24 months has spurred many investigative site owners to consider selling their businesses.

[Read More]

Bioclinica launches Clean Patient Optics

Friday, June 23, 2017

Bioclinica eHealth Solutions, which provides an agile ecosystem and domain expertise for sponsors and CROs to speed clinical development, announced the launch of Clean Patient Optics, a first-of-its kind, fully-validated clinical trial software solution that surfaces insights to patient data for accelerated database lock and clinical trial timelines. The innovative product provides uninterrupted visibility into patient data status at the study, site and patient level, empowering study teams to optimally focus the data cleaning process and remove obstacles that can create costly delays.

[Read More]

Greenphire appoints Claudine Paccio as chief operations officer

Monday, May 22, 2017

Greenphire, a global provider of automated clinical trial payment solutions, has appointed Claudine Paccio to the role of chief operations officer. Claudine comes to Greenphire with nearly three decades of experience building and leading global teams committed to operational excellence. In her role as chief operations officer, Claudine will oversee solution implementation and the ongoing success of Greenphire’s client partnerships.

[Read More]

Domestic Research Enhancement Act of 2017 endorsed by many

Tuesday, April 11, 2017

The Domestic Research Enhancement Act of 2017 (H.R. 1234), which modernizes the R&D tax credit to recognize the essential role contract research now plays in the development of new pharmaceuticals, biologics and medical devices, has been introduced by Rep. Pat Meehan (R-PA) and co-sponsors Rep. George Holding (R-NC) and G.K. Butterfield (D-NC).

[Read More]

Three Questions: Jeff Pohlig, Compass Research

Monday, February 6, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Jeff Pohlig, vice president, U.S. Operations for Compass Research, which is part of the Bioclinica Research Network. Compass Research, which has three locations in Central Florida, was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Bioclinica hires Kraus, Zaim, Levy assume key roles

Monday, January 23, 2017

Bioclinica, a provider of specialized science and technology-enabled services supporting clinical trials, has announced three executive additions to its global Medical Imaging & Biomarkers leadership team. With global headquarters in Princeton, New Jersey, Bioclinica’s Medical Imaging & Biomarkers business segment is the world clinical trial leader in medical imaging, providing cardiac safety monitoring services, specialized biochemical marker analysis, and clinical lab services in the Bioclinica molecular marker laboratory. Joining Bioclinica are Andrew Kraus, chief operating officer; Souhil Zaim, M.D., head of Global Medical and Science Affairs; and Sara Levy, vice president, Client Services. All three will report to David Herron, president, Medical Imaging & Biomarkers.

[Read More]